Page 3«..2345..10..»

Category Archives: Batten Disease Treatment

Elevated Troponin and Mortality Risk in Patients Hospitalized With COVID-19 – The Cardiology Advisor

Posted: Published on November 5th, 2020

Patients who are hospitalized with coronavirus disease 2019 (COVID-19) and have an elevated vs normal troponin levels were found to be at higher risk for death, according to a study published in the American Journal of Cardiology. Researchers reviewed data for all patients with COVID-19 who were admitted to hospitals within the Northwell Health system in New York between March 1, 2020 and April 27, 2020, and had a troponin assessment within 48 hours of admission Continue reading

Posted in Batten Disease Treatment | Comments Off on Elevated Troponin and Mortality Risk in Patients Hospitalized With COVID-19 – The Cardiology Advisor

Single versus bilateral internal thoracic artery grafting in patients with low ejection fraction – DocWire News

Posted: Published on November 5th, 2020

This article was originally published here Medicine (Baltimore). 2020 Oct 30;99(44):e22842. Continue reading

Posted in Batten Disease Treatment | Comments Off on Single versus bilateral internal thoracic artery grafting in patients with low ejection fraction – DocWire News

Protagonist Therapeutics to Participate in the HC Wainwright 22nd Annual Global Investment Conference – PRNewswire

Posted: Published on September 12th, 2020

NEWARK, Calif., Sept. 10, 2020 /PRNewswire/ --Protagonist Therapeutics, Inc. (NASDAQ:PTGX) today announced that Dinesh V Continue reading

Posted in Batten Disease Treatment | Comments Off on Protagonist Therapeutics to Participate in the HC Wainwright 22nd Annual Global Investment Conference – PRNewswire

Immunic, Inc. Publishes Full Unblinded Clinical Data From Phase 2 EMPhASIS Trial of IMU-838 in Patients With Relapsing-Remitting Multiple Sclerosis…

Posted: Published on September 12th, 2020

NEW YORK, Sept. 11, 2020 /PRNewswire/ --Immunic, Inc. (Nasdaq: IMUX),a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced that the full unblinded clinical data set from the company's phase 2 EMPhASIS trial of lead asset, IMU-838, a selective oral DHODH inhibitor, in patients with relapsing-remitting multiple sclerosis (RRMS) is now available and expands on and confirms the company's previously announced positive top-line results Continue reading

Posted in Batten Disease Treatment | Comments Off on Immunic, Inc. Publishes Full Unblinded Clinical Data From Phase 2 EMPhASIS Trial of IMU-838 in Patients With Relapsing-Remitting Multiple Sclerosis…

Forsythia is an herbal remedy that may have antibacterial and antiviral properties – Insider – INSIDER

Posted: Published on September 12th, 2020

Forsythia is a shrub that produces fruits called Lian Qiao, which is used as a medicinal herb in traditional Chinese medicine. In the past, Lian Qiao has been used to help treat various symptoms including fever, nausea, and sore throat Continue reading

Posted in Batten Disease Treatment | Comments Off on Forsythia is an herbal remedy that may have antibacterial and antiviral properties – Insider – INSIDER

Aromas Identified in Dog Food That Are Most Appealing to Canines – Technology Networks

Posted: Published on September 12th, 2020

Credit: Pixabay. Continue reading

Posted in Batten Disease Treatment | Comments Off on Aromas Identified in Dog Food That Are Most Appealing to Canines – Technology Networks

Hyponatremia in Heart Failure Linked to High-Dose Furosemide, Spironolactone – Renal and Urology News

Posted: Published on September 2nd, 2020

High doses of the diuretics furosemide and spironolactone, or concomitant use of these drugs regardless of dose, appear to be an important cause of hyponatremia in patients hospitalized with heart failure (HF), according to investigators. Continue reading

Posted in Batten Disease Treatment | Comments Off on Hyponatremia in Heart Failure Linked to High-Dose Furosemide, Spironolactone – Renal and Urology News

Covid-19 is helping to destigmatize mental healthcare in Africa – Quartz Africa

Posted: Published on July 5th, 2020

Laide Akinsemoyin has been working as a volunteer doctor in an isolation ward for coronavirus patients in Lagos, Nigeria since April. Each day, before her shift, she has to enter a donning room, to slowly and carefully put on the personal protective equipment that stands between her and possible infection from Covid-19. Akinsemoyin previously worked as a general practitioner in private practice. Continue reading

Posted in Batten Disease Treatment | Comments Off on Covid-19 is helping to destigmatize mental healthcare in Africa – Quartz Africa

Maternity Care in the Time of COVID-19 – DailyNurse

Posted: Published on June 2nd, 2020

Listen to this article. While so many businesses are shut down and people are staying at home, theres one thing that will keep happening no matter whatwomen are still having babies and need access to safe maternity care during the COVID-19 pandemic. In this dangerous and uncertain time, we wanted to know whats going on in labor and delivery (L&D)at least from one nurses perspective. Continue reading

Posted in Batten Disease Treatment | Comments Off on Maternity Care in the Time of COVID-19 – DailyNurse

Nitric oxide being tested as an experimental treatment for COVID-19 – CTV News

Posted: Published on June 2nd, 2020

TORONTO -- In the race to find an effective, low-cost treatment for COVID-19, a powerful molecule that has long captured the attention of medical researchers is gaining popularity. Nitric oxide, a two-part nanomolecule made in the cells that line the blood vessels, is being examined as an experimental treatment for the disease caused by the novel coronavirus. Continue reading

Posted in Batten Disease Treatment | Comments Off on Nitric oxide being tested as an experimental treatment for COVID-19 – CTV News

Page 3«..2345..10..»